Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epigenetic programs in ocular tissues comprise the dynamic and heritable modifications of chromatin and DNA—such as DNA methylation, histone modifications, and regulation by non-coding RNAs—that control gene expression during eye development, tissue specification, and maintenance. These mechanisms are essential for normal function and homeostasis of the retina, retinal pigment epithelium, the lens, and other ocular structures, and their dysregulation has been implicated in a wide range of eye diseases, including cataract, glaucoma, diabetic retinopathy, age-related macular degeneration, and ocular tumors. Epigenetic patterns in eye cells can be influenced by environmental exposures, aging, oxidative stress, and disease states. While not a singular druggable entity, the collective processes of epigenetic regulation are considered promising therapeutic entry points, with ongoing research focused on targeting specific regulatory enzymes and pathways in ocular disease contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epigenetic programs in ocular tissues.